Home  /  News & Magazines Apps  / Oncohematology
Oncohematology Application icon

Oncohematology 0.2.2

9.4 MB / 1+ Downloads / Rating 5.0 - 1 reviews


See previous versions

Oncohematology, developed and published by Your Digital Publishing, LLC, has released its latest version, 0.2.2, on 2016-04-29. This app falls under the News & Magazines category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

Oncohematology APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.elpub.oncohematology

Updated: 9 years ago

Developer Name: Your Digital Publishing, LLC

Category: News & Magazines

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing Oncohematology on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

5.0
Total 1 reviews

Previous Versions

Oncohematology 0.2.2
2016-04-29 / 9.4 MB / Android 2.3+

About this app

"PH "ABV-Press"", LLC

“Oncohematology” - academic and research peer-reviewed quarterly color journal. Founded in 2005

Since 2007 it was included into the List of the leading scientific journals and publications defined by the Higher Attestation Commission (HAC).

Chief editor: Honored Doctor of Russia, Professor of the Faculty of Children’s Hematology and Oncology of SBEI HPE “Russian Research Medical University named after N.I. Pirogov” at the Ministry of Health of Russia – Samochatova Elena Vladimirovna”

Target audience: hematologists, oncohematologists, chemotherapists, surgeons, experts of the large pharmaceutical companies.

Content: original opinion articles, scientific reviews, lectures of the leading national and international specialists referred to new modern methods of blood diseases diagnostics and treatment. The issue reflects an up-to-date level of research in the field of oncohematology.


Frequency: 4 issues per year.
Format: А4.
Volume: 60-90 pages.
Circulation: 3 thousand copies
Disrtibution: addressed in the territory of the Russian Federation and CIS countries.
Index of subscription: in the “Press of Russia” catalogue – 42167.
Information about types of advertising in the printed publications can be found in "Advertising in printed publications " section.

Medical specialists can subscribe to the journal for free. You shall register in the publisher site “ABV-press”, fill in the address information in the "personal account" and noted in the "subscription" edition, which you want to receive.

Medical specialists can subscribe to the journal for free. You shall register in the site of the “ABV-press” publishing house, fill the address information in the "account" and mark the publications which you would like to receive in the "subscription" section.

ISSN: 1818-8346 (Print)
ISSN: 2413-4023 (Online)

App Permissions

Allows applications to open network sockets.
Allows an application to write to external storage.
Allows access to the vibrator.
Allows an application to read from external storage.